北美放射治疗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00025051
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 150
Buy Now

North America Radiotherapy Market Growth, Share by 2031

Buy Now

北美放射治疗市场规模预计将从 2023 年的 38.5 亿美元增至 2031 年的 84.6 亿美元。预计 2023 年至 2031 年期间,市场复合年增长率将达到 10.3%。全球癌症发病率上升很可能继续成为市场趋势。

北美放射治疗市场分析

放射治疗或放射疗法是一种癌症治疗方法。这种治疗使用强能束消灭癌细胞,同时保护周围健康组织免受辐射照射。X 射线通常用于放射治疗。然而,许多其他形式的放射疗法,如质子辐射,也正在获得关注。

由于报销情况的改善以及政府和私人投资的增加以满足日益增长的癌症治疗需求,市场参与者应该期望看到广泛的增长机会。例如,2016 年有 305 万美国人接受了放射治疗,预计到 2040 年这一数字将增长约 37%,达到 417 万。

北美放射治疗市场概况

先进医疗设备的日益普及、技术进步以及癌症患病率的上升是预计在未来几年推动市场增长的几个因素。医疗设备的日益数字化、先进医疗设备技术的日益普及、对改善治疗结果的日益重视以及癌症患病率的上升都是可能推动市场增长的因素。根据美国癌症协会 2024 年发布的一项研究,美国约有 13,820 名女性被诊断出患有宫颈癌。

North America Radiotherapy Market: Strategic Insights

North America Radiotherapy Market

  • CAGR (2023 - 2031)
    10.3%
  • Market Size 2023
    US$ 3.85 billion
  • Market Size 2031
    US$ 8.46 billion

Market Dynamics

GROWTH DRIVERS
  • 癌症发病率上升
FUTURE TRENDS
  • 增加会议和研讨会的数量以提高人们对放射治疗的认识
OPPORTUNITIES
  • 癌症筛查计划和标准指南的实施

Key Players

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Sumitomo Heavy Industries Ltd
  • Elekta AB
  • Hitachi Ltd
  • Koninklijke Philips NV
  • Brainlab AG
  • PROTOM INTERNATIONAL

Regional Overview

  • 北美(美国、加拿大、墨西哥)

Market Segmentation

类型(产品、软件)
    应用(乳腺癌、肺癌、前列腺癌、结直肠癌、淋巴瘤、肝癌、甲状腺癌、脑癌、宫颈癌、脊柱癌、其他)
      最终用户(医院、放射治疗中心、专科诊所)

        北美放射治疗市场驱动因素和机遇

        越来越多的会议和研讨会以提高人们对放射治疗的认识

        在过去几年中,对癌症早期发现以及癌症治疗和管理新技术开发的研究活动的投资有所增加。教育和研究中心、医疗机构和市场参与者积极参加众多会议和研讨会,以分享知识并展示新技术。此外,此类项目对传播放射治疗意识做出了突出贡献。巴罗神经研究所的常春藤脑肿瘤中心于 2024 年 3 月举办了一次放射治疗研讨会,为与会者提供了一个扩展其知识和熟练程度的机会,让他们能够了解与放射肿瘤学和其他相关领域相关的最新程序和疗法。此外,美国放射技术员协会将于 2024 年 9 月宣布其计划,提议举办 2024 年放射治疗会议。全球领先的放射肿瘤学专业人士,包括放射治疗师和医学剂量师,将参加 ASRT 放射治疗会议,讨论该领域的创新和未来。会议将让治疗师分享他们的想法和放射治疗的新方面。此外,2022 年 7 月,马里兰大学医学院举办了一次关于放射肿瘤学实用人工智能的研讨会。此类会议和会议促进了全球的创新和新产品开发。因此,为提高人们对放射治疗的认识而举办的会议和研讨会越来越多,推动了这一进程。

        癌症筛查计划和标准指南的实施

        预防性医疗保健和疾病诊断计划的实施正在北美各地不断增加。例如,加拿大所有省份都为 50-74 岁的女性提供乳腺癌筛查计划。不列颠哥伦比亚省省级卫生服务管理局有一个乳腺癌筛查计划,为大量人口提供简单、廉价的检测;该计划主要旨在早期诊断乳腺癌。此外,2020 年 11 月,世卫组织宣布启动一项战略计划,以加速消除宫颈癌。该组织宣布了实现这一目标的三个关键步骤:接种疫苗、筛查和治疗。

        此外,CDC 是综合癌症控制国家伙伴关系 (CCCNP) 的 19 个国家组织之一。其主要目标是支持各州、领地、部落和美国太平洋岛屿管辖区的综合癌症控制联盟。此类项目可能会促进癌症检测,为整个地区采用放射治疗创造有利环境。

        各国政府和医疗机构正致力于实施战略指导方针和政策。例如,2021 年 3 月,国际原子能机构 (IAEA) 和世卫组织合作发布了采购放射治疗的新指南,以改善全球放射治疗的可及性。这些新技术指南侧重于选择放射治疗设备、其使用以及医疗机构的质量维护。这些组织发布这些指南是为了提高中低收入国家对放射治疗的采用和认识。

        因此,预计癌症筛查计划和标准指南的实施将成为预测期内北美放射治疗市场增长的有利可图的机会。

        北美放射治疗市场报告细分分析

        有助于得出北美放射治疗市场分析的关键细分市场是类型、应用和最终用户

        • 根据类型,北美放射治疗市场分为 产品和软件。产品部分在 2023 年占据了更大的市场份额。
        • 根据应用,市场细分为乳腺癌、肺癌、前列腺癌、结直肠癌、淋巴瘤、肝癌、甲状腺癌、脑癌、宫颈癌、脊柱癌等。乳腺癌部分在 2023 年占据了最大的份额。
        • 就最终用户而言,市场细分为医院、放射治疗中心和专科诊所。医院部分在 2023 年占据了市场主导地位。

        按地区划分的北美放射治疗市场份额分析

        北美放射治疗市场报告的地理范围主要分为三个国家:美国、加拿大和墨西哥。推动市场发展的关键因素包括癌症患病率上升以及为提高人们对放射治疗的认识而举办的会议和研讨会数量不断增加。

        北美放射治疗市场报告范围

        北美放射治疗市场新闻和最新发展

        北美放射治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了北美放射治疗市场的一些发展:

        • Elekta 宣布,其 Elekta Unity MR-Linac 的综合运动管理 (CMM) 具有 True Tracking 和自动门控功能,已获得美国 FDA 510(k) 批准。True Tracking 是放射治疗历史上的一个里程碑。Elekta Unity 首次在美国能够连续计算身体任何部位肿瘤的运动并自动进行计算。此功能将使临床医生能够利用增强的自适应放射治疗工作流程来处理移动器官并更准确地治疗患者。(来源:Elekta,新闻稿,2023 年 2 月)
        • 国际原子能机构 (IAEA) 与西门子医疗联手加强中低收入国家的癌症诊断和治疗能力,以新的方式利用彼此的技术专长来对抗这种每年导致数百万人死亡的疾病日益加重的全球负担。(来源:西门子医疗,时事通讯,2023 年 9 月)

        北美放射治疗市场报告覆盖范围和可交付成果

        “北美放射治疗市场规模和预测(2021 年和 2031 年)”报告提供了涵盖以下领域的市场详细分析:

        • 北美放射治疗市场规模,以及涵盖范围内所有关键细分市场的全球、区域和国家/地区预测
        • 北美放射治疗市场趋势以及市场动态,如驱动因素、限制因素和关键机会
        • 详细的 PEST/Porter 五力和 SWOT 分析
        • 北美放射治疗市场分析,涵盖关键市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
        • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和北美放射治疗市场的最新发展
        • 详细的公司简介

        North America Radiotherapy Market Report Scope

        Report Attribute Details
        Market size in US$ 3.85 billion
        Market Size by US$ 8.46 billion
        Global CAGR 10.3%
        Historical Data 2021-2022
        Forecast period 2023-2031
        Segments Covered By 类型(产品、软件)
        By 应用(乳腺癌、肺癌、前列腺癌、结直肠癌、淋巴瘤、肝癌、甲状腺癌、脑癌、宫颈癌、脊柱癌、其他)
        By 最终用户(医院、放射治疗中心、专科诊所)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        Market leaders and key company profiles
      • Siemens Healthineers AG
      • Accuray Incorporated
      • Sumitomo Heavy Industries Ltd
      • Elekta AB
      • Hitachi Ltd
      • Koninklijke Philips NV
      • Brainlab AG
      • PROTOM INTERNATIONAL
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        Frequently Asked Questions


        Which end user segment is dominating the North America radiotherapy market?

        The North America radiotherapy market by end user, is categorized into is categorized into hospitals, radiation therapy centers, and specialty clinics. The hospitals segment held the largest share of the market in 2023.

        Which application form segment is dominating the North America radiotherapy market?

        The North America radiotherapy market by application form is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. The breast cancer segment held the largest North America radiotherapy market share in 2023.

        Which type segment is dominating the North America radiotherapy market?

        The North America radiotherapy market, based on type, is segmented into products and software. The products segment held a larger share of the market in 2023.

        Which country is dominated the North America radiotherapy market?

        US holds the largest market share in North America radiotherapy market. There are several initiatives by the government and healthcare authorities to encourage the adoption of radiotherapy. Such strategies are likely to have a constructive impact on the US radiotherapy market. For instance, in June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guideline focuses on precisely implementing steps and processes to conduct radiation therapy. All these factors are expected to fuel the US radiotherapy market by 2031

        What are the driving factors for the North America radiotherapy market across the globe?

        The factors that are driving growth of the market are the rising prevalence of cancer and increasing number of conferences and symposiums to boost awareness about radiation therapy.

        Who are the major players in the North America radiotherapy market?

        The North America radiotherapy market majorly consists of the players such as Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries Ltd, Elekta AB, Hitachi Ltd, Koninklijke Philips NV, Brainlab AG, and PROTOM INTERNATIONAL.

        What is radiotherapy?

        One kind of cancer treatment is radiation therapy, sometimes known as radiotherapy. Intense energy beams are used in this treatment to eradicate cancer cells. X-rays are most frequently used in radiation therapy. However, there are other forms of radiation therapy, such as proton radiation.

        The List of Companies - North America Radiotherapy Market

        1. Siemens Healthineers AG
        2. Accuray Incorporated
        3. Sumitomo Heavy Industries Ltd
        4. Elekta AB
        5. Hitachi Ltd
        6. Koninklijke Philips NV
        7. Brainlab AG
        8. PROTOM INTERNATIONAL

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Trends and growth analysis reports related to Medical Device : READ MORE..